Floatz logo

Monomethyl Fumarate

Hepatocellular Carcinoma

Wondercel Biotech (ShenZhen)Small moleculePhase 4 / ApprovedActive
B
63/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
65/ 100

Competitive context

262 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Calcium folinate pentahydrate
Li Qiang
Phase 4BB
Eloxatin
Li Qiang
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB

View all 50 →

Same molecule, other indications

Monomethyl Fumarate is also rated in:

Blood Stem Cell Transplant FailureDormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi AnemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Refractory Anemia With Excess BlastsDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →